The purpose of this study is to obtain on-eye performance data to inform contact lens product development and to further evaluate product performance in the intended population.

The expected duration of subject participation in the study is approximately 20 days with 3 scheduled visits. Each subject will evaluate the test contact lenses compared to 1 of 3 commercially available contact lenses.

Inclusion Criteria:

• Able to understand and must sign an approved Informed Consent Form
• Successfully wears daily disposable spherical soft contact lenses in both eyes for a minimum of 5 days per week and 8 hours per day during the past 3 months
• Best Corrected Visual Acuity of 20/25 Snellen or better in each eye
• Willing to stop wearing habitual contact lenses for the duration of study participation
• Other protocol-defined inclusion criteria may apply

Exclusion Criteria:

• Any eye condition, surgery, disease, or use of medication that contraindicates contact lens wear, as determined by the Investigator.
• Routinely sleeps in habitual contact lenses
• Currently wears Oasys 1-Day, MyDay, or Moist contact lenses
• Other protocol-defined exclusion criteria may apply

This analysis population includes all subjects/eyes exposed to any study lenses evaluated in this study (Safety Analysis Set).

Dispense through study completion, an average of 2 weeks

An adverse event (AE) was defined as any untoward medical occurrence, unintended disease or injury, or untoward clinical signs in subjects, users, or other persons, whether or not related to the investigational medical device. AEs were obtained through solicited and spontaneous comments from subjects and through observations by the Investigator as outlined in the study protocol. Safety Analysis Set, based on treatment-specific exposure.